From the impact of Obamacare to cutting edge research, from biotech buyouts to big pharma court battles, the Motley Fool's health-care team sits down each week to discuss the most fascinating developments across the health-care industry, and their implications for long-term investors. In this week's edition, the team talks about big pharma patent disputes, stocks that have both popped and plummeted, and companies our analysts will be watching in the coming days.
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
The Motley Fool Health-Care Show for Friday April 5th.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.